Walker named new COO of City of Hope

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Jeff Walker, formerly a chief operating officer at Ohio State University, has been named COO of City of Hope.

Walker has more than two decades of experience in cancer center leadership and transformation. He joined City of Hope earlier this year as senior vice president in transformation development and has been leading the institution’s efforts around operational design and planning for new strategic initiatives and ventures.

As COO, Walker will lead patient care operations for the Duarte, California, campus and all community practice locations as well as all research operations. He will oversee the management of the enterprise-wide physical plant, including an estimated $1.1 billion in new construction projects.

Prior to coming to City of Hope, Walker served as the chief operating officer for The Ohio State University Comprehensive Cancer Center and the James Cancer Hospital, overseeing and integrating the administrative and operational structure to support the program’s research and clinical missions. During his tenure, the new James Cancer Hospital was built and opened, becoming the third largest cancer hospital in the country.

Walker has also served as executive vice president for the Roswell Park Cancer Research Institute in New York and, prior to his roles at Ohio State and Roswell Park, he held administrative leadership positions at the University of Pittsburgh Cancer Institute during his 14 years at UPCI.

Walker serves as vice-chair of the Alliance of Dedicated Cancer Center executive committee, treasurer of the Association of American Cancer Institutes, and is a member of the executive and finance committees of the National Comprehensive Cancer Network and the Cancer Center Administrators Forum.

YOU MAY BE INTERESTED IN

The nagging pain in Mia Sandino’s right knee set in in September 2018, and throughout her freshman year at the University of Washington, she tried to ignore it. “I was being a very naive and invincible-feeling 19-year-old,” Sandino told The Cancer Letter. “I didn’t put two and two together that this area of the knee that...

Rick Pazdur, MD, the newly appointed director for the Center for Drug Evaluation and Research at the FDA, has been described as “greyhound thin” as a result of his dedication to cycling and lifting weights in the gym each day and, for a long time, a vegetarian diet. I first met him when he was the director of the Office of Oncology Drug Products (ODP) within CDER, in 2009.
When it comes to fighting cancer today, collaboration is key. At a time when funding is uncertain, yet innovative breakthroughs are accelerating every day, it’s more important than ever for oncologists, scientists, academic researchers, and community physicians, to come together to share knowledge and gain insights about the forefront of cancer research.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login